Posters & Talks

2007

"Oxygen and Proton Fluxes Enable Kinetic Studies of Fatty Acid Oxidation and Mitochondrial Function"

Targeting Obesity Meeting
September 26th @ 13:50pm EDT
London, UK
Speaker: David Ferrick, PhD, VP Assay Development

"Real-time, Cell Respiration Assays Provide Valuable Insight to Metabolic Drug Discovery"

Diabetes
October 29th @ 13:30pm EDT
London, UK
Speaker: David Ferrick, PhD, VP Assay Development

"Using Real-time Metabolic Measurements of Cells to Predict Behavior in a Bioreactor"

Optimizing Cell Culture Development
September 18th @ 10:05am
Boston, MA
Speaker: George Rogers, PhD, Field Application Specialist

Learn More

"Mitochondria: An Attractive Target for Drug Discovery and a Concern for Drug Safety"

MIP2007
September 18th@ 10:15am
Ambleside, United Kingdom
Speaker: David Ferrick, PhD, VP Assay Development

"Metformin-Induced Inhibition of Mitochondrial Complex I Activity Stimulates Fatty Acid Oxidation and Glycolysis While Blunting Glucose Oxidation in C2C12 Myocytes"

Molecular & Cellular Bioenergetics
June 17, 2007
Andover, New Hampshire
Presenter: Min Wu, PhD, Assay and Application Development Manager
View the Poster (PDF)

"Oxygen and Proton Fluxes Enable Real-Time Metabolic Measurements."

Targeting Metabolic Syndrome
February 26, 2007
Boston, MA
Speaker: David Ferrick, PhD, VP Assay Development

"Simultaneous, Kinetic Analysis of Oxygen Consumption and Glycolysis Rate Demonstrates that Inhibition of Acetyl-CoA Carboxylase (ACC) Causes a Sustainable Increase in Fatty Acid Oxidation (FAO) and a Concomitant but Transient Increase in Glycolysis."

Diabetes and Obesity
January 14, 2007
Keystone Colorado
Presenter: Min Wu, PhD, Assay and Application Development Manager
View the Poster (PDF)

2006

October 2, 2006

Seahorse Bioscience to speak on "Accelerating Metabolic Drug Discovery" at SMi's Metabolic Diseases Forum: A Focus on Diabetes, Obesity & Related Disorders being held October 2-3 in London, England.

September 27, 2006

Seahorse Bioscience to speak on "Eliminating the Bottleneck in Metabolic Drug Discovery" at Marcus Evan's Metabolic Syndrome Conference being held on September 25-27 in Cambridge, Massachusetts.

September 10, 2006

Seahorse Bioscience to present "“2-Deoxyglucose Induces a Metabolic Switch to Mitochondrial Oxidative Energy Metabolism Resulting in Sensitization to Apoptosis of Glioblastoma Cells”" at Gordon Conference held September 10-12 in Big Sky Montana.

July 27, 2006

Seahorse Bioscience to speak on "Increase Lead Optimization with a Non-Radiometric Assay for Measuring Fatty Acid Oxidation" at CBI's 2nd Annual Obesity Drug Development Summit being held on July 27 in McLean, Virginia.

July 24, 2006

Seahorse Bioscience to speak on "Increase Lead Optimization with Extracellular Flux" at SRI's 5th Annual Metabolic Disease Summit being held on July 24 in San Diego, California.

February 9, 2006

Seahorse Bioscience to speak on “Cancer: Will its sweet tooth be its undoing?” at the 3rd Cancer Drugs Research and Development meeting which is being held in San Francisco, California on February 9, 2006.

January 26, 2006

Seahorse Bioscience data included in Nature letter "Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation"

January 22, 2006

Seahorse Bioscience presents the poster "Extracellular Flux Enables Real-time, Non-invasive Measurements of Cellular Metabolism" at LabAutomation 2006 in Palm Springs, California.

2005

October 15, 2005

Seahorse Bioscience presents the poster "Extracellular Flux as an Indicator of Cellular Metabolism" at the NAASO annual meeting held in Vancouver, British Columbia

October 7,2005

Seahorse Bioscience presents the poster A Novel Assay for Profiling Metabolic Changes Mediated by HIF-1a in Cancer Cells at Tumor Metabolism Summit in Genoa, Italy.

September 19, 2005

Seahorse Bioscience poster "A Novel Technology for Profiling Energy Metabolism in Cancer Cells" wins award at 2nd Tumor Progression & Therapeutic Resistance Meeting.

August 1, 2005

Seahorse Bioscience Jay Teich is interviewed in Next Generation Pharmaceutical: "The End of Endpoint Assays." Read the article here...

June 29, 2005

Seahorse Bioscience speaks on "A Non-destructive, Time-resolved, Multi-analyte, Technology for Measuring the Physiologic Response of Cells In vitro " at the Metabolic Diseases Summit held in San Francisco, CA

July 21, 2005

Seahorse Bioscience speaks on "Non-Invasive Extracellular Flux Rate Measurements Profile the Impact of Compounds on Cellular Metabolism" at the Obesity Drug Development Summit Summit

May 27, 2005

Seahorse Bioscience speaks on "A Non-destructive, Multi-analyte, Time-resolved Technology for Sensing Metabolic Changes in Cancer Cells" at Cancer Drug Research & Development in Philadelphia, PA

April 19, 2005

Seahorse Bioscience presents poster "A Non-destructive, Multi-analyte, Time-resolved Technology for Sensing Metabolic Changes in Cancer Cells" at the American Association for Cancer Research 2005 meeting in Anaheim, CA